Last reviewed · How we verify
NCT04087902
Long-Term Longitudinal QoL in Patients Undergoing EEA
trial in Pituitary Tumor in 400 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | Ohio State University |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 400 |
| Start date | 16 July 2019 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across United States |
Conditions studied
- Pituitary Tumor — all drugs for Pituitary Tumor →
- Meningioma — all drugs for Meningioma →
- Rathke Cleft Cysts — all drugs for Rathke Cleft Cysts →
- Chordoma — all drugs for Chordoma →
Sponsor
Ohio State University
Who can join
18 and older, any sex, with Pituitary Tumor or Meningioma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective longitudinal study to access postoperative 2-year quality of life in patients who undergo endonasal endoscopic approach surgeries of the skull base.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04087902
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pituitary Tumor
Currently open trials in the same condition.
- NCT06936813 — The PROMISE Survey · active not recruiting
- NCT06705036 — Differential Study of Invasive Pituitary Adenomas in the Sellar and Cavernous Sinus Regions · recruiting
- NCT06472505 — Using Polyglycolic Acid Mesh Prevents Cerebrospinal Fluid Leakage · NA · recruiting
- NCT06523582 — Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients · recruiting
- NCT05659524 — Nasal Outcomes Using Saline Irrigations After Endonasal Pituitary Surgery · NA · recruiting
Other Ohio State University trials
Trials by the same sponsor.
- NCT06542458 — Under-Represented Communities Diagnosed With SCD or MCI Through Tele-Cog · not yet recruiting
- NCT07217548 — Solving Stigma Through POV Simulation: Enhancing Pharmacist Empathy-based Practices With Sickle Cell Disease Patients · NA · enrolling by invitation
- NCT07215221 — Implementation of TBI-RECOVER in Substance Use Treatment · NA · not yet recruiting
- NCT07278427 — Reducing Parental Substance Use and Enhancing Family Resilience Among Rural Families Through Ohio START · recruiting
- NCT07490444 — Metric-Optimized Spectacle Prescriptions for Children With Down Syndrome · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04087902 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ohio State University
- Last refreshed: 3 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04087902.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing